Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oliver Distler

Showing results (491-500 of 622) with videos related to

Pageof 63
Sort By:
Arthritis Research & Therapy|November 1, 2024
Does regression of skin thickening predict improvement of internal organ involvement and survival in patients with diffuse cutaneous systemic sclerosis? A EUSTAR analysisAnja Wyss, Suzana Jordan, Nicole Graf, et al.
Swiss Medical Weekly|July 20, 2021
The burden of systemic sclerosis in Switzerland - the Swiss systemic sclerosis EUSTAR cohortJasmin Hernández, Suzana Jordan, Rucsandra Dobrota, et al.
Clinical and Experimental Rheumatology|July 1, 2017
Clinical determinants of elevated systolic pulmonary artery pressure measured by transthoracic Doppler echocardiography in early systemic sclerosisPatricia E Carreira, Loreto Carmona, Beatriz E Joven, et al.
Annals of the Rheumatic Diseases|October 25, 2014
A gender gap in primary and secondary heart dysfunctions in systemic sclerosis: a EUSTAR prospective studyMuriel Elhai, Jérôme Avouac, Ulrich A Walker, et al.
Journal of Scleroderma and Related Disorders|August 25, 2025
Treatment recommendations for the systemic pharmacological treatment of systemic sclerosis digital ulcers: Results from the World Scleroderma Foundation Ad Hoc CommitteeNancy Maltez, Laura Ross, Murray Baron, et al.
The Lancet. Respiratory Medicine|January 7, 2021
Efficacy and safety of nintedanib in patients with systemic sclerosis-associated interstitial lung disease treated with mycophenolate: a subgroup analysis of the SENSCIS trialKristin B Highland, Oliver Distler, Masataka Kuwana, et al.
RMD Open|February 10, 2025
How to build a framework to establish a patient research partner network in rheumatology research: a report of a 2-year implementation projectKristina Buerki, Melpomeni Toitou, Maarten de Wit, et al.
The Lancet. Rheumatology|January 24, 2024
Stratification in systemic sclerosis according to autoantibody status versus skin involvement: a study of the prospective EUSTAR cohortMuriel Elhai, Nanthara Sritharan, Marouane Boubaya, et al.
Clinical and Experimental Rheumatology|October 3, 2018
Gender differences in early systemic sclerosis patients: a report from the EULAR scleroderma trials and research group (EUSTAR) databasePatricia E Carreira, Loreto Carmona, Beatriz E Joven, et al.
Rheumatology (Oxford, England)|July 29, 2022
Use of platelet inhibitors for digital ulcers related to systemic sclerosis: EUSTAR study on derivation and validation of the DU-VASC modelAlexandru Garaiman, Klaus Steigmiller, Catherine Gebhard, et al.
Pageof 63

Showing results (491-500 of 622) with videos related to

Sort By:
Pageof 63
Arthritis Research & Therapy|November 1, 2024
Does regression of skin thickening predict improvement of internal organ involvement and survival in patients with diffuse cutaneous systemic sclerosis? A EUSTAR analysisAnja Wyss, Suzana Jordan, Nicole Graf, et al.
Swiss Medical Weekly|July 20, 2021
The burden of systemic sclerosis in Switzerland - the Swiss systemic sclerosis EUSTAR cohortJasmin Hernández, Suzana Jordan, Rucsandra Dobrota, et al.
Clinical and Experimental Rheumatology|July 1, 2017
Clinical determinants of elevated systolic pulmonary artery pressure measured by transthoracic Doppler echocardiography in early systemic sclerosisPatricia E Carreira, Loreto Carmona, Beatriz E Joven, et al.
Annals of the Rheumatic Diseases|October 25, 2014
A gender gap in primary and secondary heart dysfunctions in systemic sclerosis: a EUSTAR prospective studyMuriel Elhai, Jérôme Avouac, Ulrich A Walker, et al.
Journal of Scleroderma and Related Disorders|August 25, 2025
Treatment recommendations for the systemic pharmacological treatment of systemic sclerosis digital ulcers: Results from the World Scleroderma Foundation Ad Hoc CommitteeNancy Maltez, Laura Ross, Murray Baron, et al.
The Lancet. Respiratory Medicine|January 7, 2021
Efficacy and safety of nintedanib in patients with systemic sclerosis-associated interstitial lung disease treated with mycophenolate: a subgroup analysis of the SENSCIS trialKristin B Highland, Oliver Distler, Masataka Kuwana, et al.
RMD Open|February 10, 2025
How to build a framework to establish a patient research partner network in rheumatology research: a report of a 2-year implementation projectKristina Buerki, Melpomeni Toitou, Maarten de Wit, et al.
The Lancet. Rheumatology|January 24, 2024
Stratification in systemic sclerosis according to autoantibody status versus skin involvement: a study of the prospective EUSTAR cohortMuriel Elhai, Nanthara Sritharan, Marouane Boubaya, et al.
Clinical and Experimental Rheumatology|October 3, 2018
Gender differences in early systemic sclerosis patients: a report from the EULAR scleroderma trials and research group (EUSTAR) databasePatricia E Carreira, Loreto Carmona, Beatriz E Joven, et al.
Rheumatology (Oxford, England)|July 29, 2022
Use of platelet inhibitors for digital ulcers related to systemic sclerosis: EUSTAR study on derivation and validation of the DU-VASC modelAlexandru Garaiman, Klaus Steigmiller, Catherine Gebhard, et al.
Pageof 63